An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor
Objective To evaluate the safety and effectiveness of a wrist‐worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single in‐office session. Methods This was a randomized controlled study of 77 ET patients who received either treatment stimulation (N = 40) or sham sti...
Saved in:
Published in | Neuromodulation (Malden, Mass.) Vol. 22; no. 5; pp. 537 - 545 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Limited
01.07.2019
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1094-7159 1525-1403 1525-1403 |
DOI | 10.1111/ner.12930 |
Cover
Loading…
Abstract | Objective
To evaluate the safety and effectiveness of a wrist‐worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single in‐office session.
Methods
This was a randomized controlled study of 77 ET patients who received either treatment stimulation (N = 40) or sham stimulation (N = 37) on the wrist of the hand with more severe tremor. Tremor was evaluated before and immediately after the end of a single 40‐minute stimulation session. The primary endpoint compared spiral drawing in the stimulated hand using the Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS) Archimedes spiral scores in treatment and sham groups. Additional endpoints included TETRAS upper limb tremor scores, subject‐rated tasks from the Bain and Findley activities of daily living (ADL) scale before and after stimulation as well as clinical global impression‐improvement (CGI‐I) rating after stimulation.
Results
Subjects who received peripheral nerve stimulation did not show significantly larger improvement in the Archimedes spiral task compared to sham but did show significantly greater improvement in upper limb TETRAS tremor scores (p = 0.017) compared to sham. Subject‐rated improvements in ADLs were significantly greater with treatment (49% reduction) than with sham (27% reduction; p = 0.001). A greater percentage of ET patients (88%) reported improvement in the stimulation group as compared to the sham group (62%) according to CGI‐I ratings (p = 0.019). No significant adverse events were reported; 3% of subjects experienced mild adverse events.
Conclusions
Peripheral nerve stimulation in ET may provide a safe, well‐tolerated, and effective treatment for transient relief of hand tremor symptoms. |
---|---|
AbstractList | Objective
To evaluate the safety and effectiveness of a wrist‐worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single in‐office session.
Methods
This was a randomized controlled study of 77 ET patients who received either treatment stimulation (N = 40) or sham stimulation (N = 37) on the wrist of the hand with more severe tremor. Tremor was evaluated before and immediately after the end of a single 40‐minute stimulation session. The primary endpoint compared spiral drawing in the stimulated hand using the Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS) Archimedes spiral scores in treatment and sham groups. Additional endpoints included TETRAS upper limb tremor scores, subject‐rated tasks from the Bain and Findley activities of daily living (ADL) scale before and after stimulation as well as clinical global impression‐improvement (CGI‐I) rating after stimulation.
Results
Subjects who received peripheral nerve stimulation did not show significantly larger improvement in the Archimedes spiral task compared to sham but did show significantly greater improvement in upper limb TETRAS tremor scores (p = 0.017) compared to sham. Subject‐rated improvements in ADLs were significantly greater with treatment (49% reduction) than with sham (27% reduction; p = 0.001). A greater percentage of ET patients (88%) reported improvement in the stimulation group as compared to the sham group (62%) according to CGI‐I ratings (p = 0.019). No significant adverse events were reported; 3% of subjects experienced mild adverse events.
Conclusions
Peripheral nerve stimulation in ET may provide a safe, well‐tolerated, and effective treatment for transient relief of hand tremor symptoms. To evaluate the safety and effectiveness of a wrist-worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single in-office session. This was a randomized controlled study of 77 ET patients who received either treatment stimulation (N = 40) or sham stimulation (N = 37) on the wrist of the hand with more severe tremor. Tremor was evaluated before and immediately after the end of a single 40-minute stimulation session. The primary endpoint compared spiral drawing in the stimulated hand using the Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS) Archimedes spiral scores in treatment and sham groups. Additional endpoints included TETRAS upper limb tremor scores, subject-rated tasks from the Bain and Findley activities of daily living (ADL) scale before and after stimulation as well as clinical global impression-improvement (CGI-I) rating after stimulation. Subjects who received peripheral nerve stimulation did not show significantly larger improvement in the Archimedes spiral task compared to sham but did show significantly greater improvement in upper limb TETRAS tremor scores (p = 0.017) compared to sham. Subject-rated improvements in ADLs were significantly greater with treatment (49% reduction) than with sham (27% reduction; p = 0.001). A greater percentage of ET patients (88%) reported improvement in the stimulation group as compared to the sham group (62%) according to CGI-I ratings (p = 0.019). No significant adverse events were reported; 3% of subjects experienced mild adverse events. Peripheral nerve stimulation in ET may provide a safe, well-tolerated, and effective treatment for transient relief of hand tremor symptoms. ObjectiveTo evaluate the safety and effectiveness of a wrist‐worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single in‐office session.MethodsThis was a randomized controlled study of 77 ET patients who received either treatment stimulation (N = 40) or sham stimulation (N = 37) on the wrist of the hand with more severe tremor. Tremor was evaluated before and immediately after the end of a single 40‐minute stimulation session. The primary endpoint compared spiral drawing in the stimulated hand using the Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS) Archimedes spiral scores in treatment and sham groups. Additional endpoints included TETRAS upper limb tremor scores, subject‐rated tasks from the Bain and Findley activities of daily living (ADL) scale before and after stimulation as well as clinical global impression‐improvement (CGI‐I) rating after stimulation.ResultsSubjects who received peripheral nerve stimulation did not show significantly larger improvement in the Archimedes spiral task compared to sham but did show significantly greater improvement in upper limb TETRAS tremor scores (p = 0.017) compared to sham. Subject‐rated improvements in ADLs were significantly greater with treatment (49% reduction) than with sham (27% reduction; p = 0.001). A greater percentage of ET patients (88%) reported improvement in the stimulation group as compared to the sham group (62%) according to CGI‐I ratings (p = 0.019). No significant adverse events were reported; 3% of subjects experienced mild adverse events.ConclusionsPeripheral nerve stimulation in ET may provide a safe, well‐tolerated, and effective treatment for transient relief of hand tremor symptoms. To evaluate the safety and effectiveness of a wrist-worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single in-office session.OBJECTIVETo evaluate the safety and effectiveness of a wrist-worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single in-office session.This was a randomized controlled study of 77 ET patients who received either treatment stimulation (N = 40) or sham stimulation (N = 37) on the wrist of the hand with more severe tremor. Tremor was evaluated before and immediately after the end of a single 40-minute stimulation session. The primary endpoint compared spiral drawing in the stimulated hand using the Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS) Archimedes spiral scores in treatment and sham groups. Additional endpoints included TETRAS upper limb tremor scores, subject-rated tasks from the Bain and Findley activities of daily living (ADL) scale before and after stimulation as well as clinical global impression-improvement (CGI-I) rating after stimulation.METHODSThis was a randomized controlled study of 77 ET patients who received either treatment stimulation (N = 40) or sham stimulation (N = 37) on the wrist of the hand with more severe tremor. Tremor was evaluated before and immediately after the end of a single 40-minute stimulation session. The primary endpoint compared spiral drawing in the stimulated hand using the Tremor Research Group Essential Tremor Rating Assessment Scale (TETRAS) Archimedes spiral scores in treatment and sham groups. Additional endpoints included TETRAS upper limb tremor scores, subject-rated tasks from the Bain and Findley activities of daily living (ADL) scale before and after stimulation as well as clinical global impression-improvement (CGI-I) rating after stimulation.Subjects who received peripheral nerve stimulation did not show significantly larger improvement in the Archimedes spiral task compared to sham but did show significantly greater improvement in upper limb TETRAS tremor scores (p = 0.017) compared to sham. Subject-rated improvements in ADLs were significantly greater with treatment (49% reduction) than with sham (27% reduction; p = 0.001). A greater percentage of ET patients (88%) reported improvement in the stimulation group as compared to the sham group (62%) according to CGI-I ratings (p = 0.019). No significant adverse events were reported; 3% of subjects experienced mild adverse events.RESULTSSubjects who received peripheral nerve stimulation did not show significantly larger improvement in the Archimedes spiral task compared to sham but did show significantly greater improvement in upper limb TETRAS tremor scores (p = 0.017) compared to sham. Subject-rated improvements in ADLs were significantly greater with treatment (49% reduction) than with sham (27% reduction; p = 0.001). A greater percentage of ET patients (88%) reported improvement in the stimulation group as compared to the sham group (62%) according to CGI-I ratings (p = 0.019). No significant adverse events were reported; 3% of subjects experienced mild adverse events.Peripheral nerve stimulation in ET may provide a safe, well-tolerated, and effective treatment for transient relief of hand tremor symptoms.CONCLUSIONSPeripheral nerve stimulation in ET may provide a safe, well-tolerated, and effective treatment for transient relief of hand tremor symptoms. |
Author | Hamner, Samuel Ostrem, Jill Gwinn, Ryder Pahwa, Rajesh Chidester, Paula Dhall, Rohit Dietiker, Cameron Ross, Erika Luthra, Nijee Lyons, Kelly Ro, Susie Delp, Scott |
AuthorAffiliation | 3 University of California San Francisco San Francisco CA USA 7 Department of Bioengineering Stanford University Stanford CA USA 4 Swedish Medical Center Seattle Seattle WA USA 1 University of Kansas Medical Center Kansas City KS USA 6 Department of Neurologic Surgery Mayo Clinic Rochester MN USA 5 Cala Health, Inc. Burlingame CA USA 2 University of Arkansas for Medical Sciences Little Rock AR USA |
AuthorAffiliation_xml | – name: 6 Department of Neurologic Surgery Mayo Clinic Rochester MN USA – name: 7 Department of Bioengineering Stanford University Stanford CA USA – name: 4 Swedish Medical Center Seattle Seattle WA USA – name: 3 University of California San Francisco San Francisco CA USA – name: 2 University of Arkansas for Medical Sciences Little Rock AR USA – name: 5 Cala Health, Inc. Burlingame CA USA – name: 1 University of Kansas Medical Center Kansas City KS USA |
Author_xml | – sequence: 1 givenname: Rajesh surname: Pahwa fullname: Pahwa, Rajesh organization: University of Kansas Medical Center – sequence: 2 givenname: Rohit surname: Dhall fullname: Dhall, Rohit organization: University of Arkansas for Medical Sciences – sequence: 3 givenname: Jill surname: Ostrem fullname: Ostrem, Jill organization: University of California San Francisco – sequence: 4 givenname: Ryder surname: Gwinn fullname: Gwinn, Ryder organization: Swedish Medical Center Seattle – sequence: 5 givenname: Kelly surname: Lyons fullname: Lyons, Kelly organization: University of Kansas Medical Center – sequence: 6 givenname: Susie surname: Ro fullname: Ro, Susie organization: Swedish Medical Center Seattle – sequence: 7 givenname: Cameron surname: Dietiker fullname: Dietiker, Cameron organization: University of California San Francisco – sequence: 8 givenname: Nijee surname: Luthra fullname: Luthra, Nijee organization: University of California San Francisco – sequence: 9 givenname: Paula surname: Chidester fullname: Chidester, Paula organization: Cala Health, Inc – sequence: 10 givenname: Samuel surname: Hamner fullname: Hamner, Samuel organization: Cala Health, Inc – sequence: 11 givenname: Erika orcidid: 0000-0003-3274-6328 surname: Ross fullname: Ross, Erika organization: Mayo Clinic – sequence: 12 givenname: Scott surname: Delp fullname: Delp, Scott email: delp@stanford.edu organization: Stanford University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30701655$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9vEzEQxS1URP_AgS-AVuLSHra1vWs7viBFUQpIVUAlnC3HO6GuvHawd4PKp2fSlAoqgS-2PL95ejPvmBzEFIGQ14yeMzwXEfI547qhz8gRE1zUrKXNAb6pbmvFhD4kx6XcUsqU5uoFOWyookwKcUS6aaymbhyguraxS73_CV01S3HIKQR8LrO3oUrrapGij1tb_Baqz5D95gYyVhaQ8ePL4Psx2MGnWPlYzUuBOOwalxn6lF-S52sbCrx6uE_I18v5cvahvvr0_uNselW7tm1oLScceGfbNe9AU2utdNwxJTuwilvJFcMBXNtBq52wvFGrFdfCNQwUgHS0OSHv9rqbcdVD59AEejSb7Hub70yy3vxdif7GfEtbI5WUmnMUOH0QyOn7CGUwvS8OQrAR0lgMxwWKZqKpRPTtE_Q2jTnieIZzMVFs5xepN386erTyOwAEzvaAy6mUDOtHhFGzC9dguOY-XGQvnrDOD_dLx2F8-F_HDx_g7t_SZjG_3nf8Ajkftp8 |
CitedBy_id | crossref_primary_10_3389_fnins_2020_530300 crossref_primary_10_1186_s12984_021_00811_9 crossref_primary_10_2147_JPR_S316371 crossref_primary_10_5664_jcsm_9404 crossref_primary_10_7759_cureus_56756 crossref_primary_10_1063_5_0085850 crossref_primary_10_5334_tohm_685 crossref_primary_10_5334_tohm_762 crossref_primary_10_1055_s_0041_1726356 crossref_primary_10_52662_jksfn_2022_00220 crossref_primary_10_3390_ijerph19159233 crossref_primary_10_1212_CON_0000000000001181 crossref_primary_10_5334_tohm_798 crossref_primary_10_1002_mdc3_13418 crossref_primary_10_5334_tohm_715 crossref_primary_10_3390_jpm12010076 crossref_primary_10_1016_j_parkreldis_2024_106086 crossref_primary_10_1109_TNSRE_2022_3158606 crossref_primary_10_1016_S0140_6736_23_00055_7 crossref_primary_10_1016_j_cobme_2023_100484 crossref_primary_10_3390_s25010266 crossref_primary_10_1016_j_jpain_2020_09_003 crossref_primary_10_1002_mdc3_13395 crossref_primary_10_1080_09593985_2023_2243504 crossref_primary_10_1162_imag_a_00139 crossref_primary_10_1039_D4CS00413B crossref_primary_10_5334_tohm_991 crossref_primary_10_1016_j_ncl_2020_01_002 crossref_primary_10_1016_j_appet_2021_105807 crossref_primary_10_5334_tohm_775 crossref_primary_10_1016_j_jns_2022_120195 crossref_primary_10_36469_001c_37307 crossref_primary_10_7759_cureus_59451 crossref_primary_10_1007_s11910_022_01185_8 crossref_primary_10_1021_acsnano_2c12458 crossref_primary_10_1038_s41598_021_96660_6 crossref_primary_10_3389_fneur_2021_700600 crossref_primary_10_1080_17434440_2023_2274604 crossref_primary_10_3390_bios11040099 crossref_primary_10_1109_ACCESS_2021_3084819 crossref_primary_10_1016_j_eclinm_2024_102889 crossref_primary_10_5334_tohm_949 crossref_primary_10_1088_1741_2552_ac7665 crossref_primary_10_1109_TBME_2020_3015572 crossref_primary_10_3390_medicina56100552 crossref_primary_10_1109_JTEHM_2020_2985058 |
Cites_doi | 10.3389/fneur.2018.00257 10.1111/j.1528-1157.1994.tb02482.x 10.1016/S1474-4422(10)70322-7 10.1016/S1474-4422(05)00991-9 10.1136/jnnp.66.6.772 10.1056/NEJM200002173420703 10.1523/JNEUROSCI.0106-15.2015 10.1002/mds.27350 10.3389/fnins.2017.00178 10.1002/mds.870131303 10.1523/JNEUROSCI.3768-14.2015 10.1002/1531-8257(199909)14:5<847::AID-MDS1021>3.0.CO;2-G 10.1152/jn.90412.2008 10.1002/ana.410420304 10.1016/j.mayocp.2017.05.005 10.1017/S0317167100003413 10.1136/jnnp.50.6.704 10.1136/jnnp.56.10.1085 10.1002/mds.25796 10.1002/mds.870130105 10.1002/(SICI)1097-0258(19960715)15:13<1421::AID-SIM266>3.0.CO;2-H 10.1056/NEJMoa1600159 10.1016/S0894-1130(00)80019-8 10.1212/WNL.39.12.1587 10.1212/01.WNL.0000099075.19951.8C 10.1056/NEJMcp1707928 10.1152/jn.00363.2004 10.1093/brain/awl190 10.1016/j.parkreldis.2017.05.018 10.1016/0140-6736(91)91175-T 10.3389/fneur.2016.00060 10.1056/NEJMe1606517 10.5334/tohm.198 10.1002/mdc3.12185 10.1212/WNL.36.7.1001 10.1007/s40122-015-0039-5 10.3171/2013.10.JNS131225 10.1002/mds.27223 |
ContentType | Journal Article |
Copyright | 2019 The Authors. published by Wiley Periodicals, Inc. on behalf of International Neuromodulation Society. 2019 The Authors. Neuromodulation: Technology at the Neural Interface published by Wiley Periodicals, Inc. on behalf of International Neuromodulation Society. 2019 International Neuromodulation Society |
Copyright_xml | – notice: 2019 The Authors. published by Wiley Periodicals, Inc. on behalf of International Neuromodulation Society. – notice: 2019 The Authors. Neuromodulation: Technology at the Neural Interface published by Wiley Periodicals, Inc. on behalf of International Neuromodulation Society. – notice: 2019 International Neuromodulation Society |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK K9. 7X8 5PM |
DOI | 10.1111/ner.12930 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
DocumentTitleAlternate | PERIPHERAL NERVE STIMULATION IN ESSENTIAL TREMOR |
EISSN | 1525-1403 |
EndPage | 545 |
ExternalDocumentID | PMC6766922 30701655 10_1111_ner_12930 NER12930 |
Genre | article Randomized Controlled Trial Multicenter Study Journal Article |
GrantInformation_xml | – fundername: Cala Health, Inc. |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 24P 29N 31~ 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AALRI AAMMB AANHP AAONW AAQFI AAQQT AATTM AAXUO AAYWO AAZKR ABCQN ABCUV ABEML ABFNM ABJNI ACAHQ ACBWZ ACGFS ACIEU ACMXC ACPOU ACPRK ACRLP ACRPL ACSCC ACVFH ACXQS ACYXJ ADBBV ADCNI ADEOM ADIYS ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADZMN AEFGJ AEIMD AEIPS AENEX AEUPX AFBPY AFEBI AFGKR AFJKZ AFPUW AFXIZ AFZJQ AGCQF AGQPQ AGXDD AHMBA AIACR AIDQK AIDYY AIGII AIIUN AIKHN AITUG AIURR AJAOE AKBMS AKRWK AKYEP ALAGY ALMA_UNASSIGNED_HOLDINGS AMBMR AMRAJ AMYDB ANKPU APXCP ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BHBCM BMXJE BNPGV BROTX BRXPI BY8 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EFJIC EFKBS EJD EX3 F00 F01 F04 F5P FDB FEDTE FUBAC FYGXN G-S G.N GODZA H.X HF~ HVGLF HZI HZ~ IHE IX1 J0M K48 LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SSH SUPJJ T5K TEORI UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI XG1 YFH ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ AEEZP AEQDE AGRNS AIWBW AJBDE CITATION 1OC 33P ABDBF AEUQT AFPWT CGR CUY CVF EAD EAP ECM EIF EMK EST ESX NPM SV3 WRC 7TK K9. 7X8 5PM |
ID | FETCH-LOGICAL-c4430-682e2da4f2de90aaa6c2c176dea72a6271017c4de49c5a237bb295c31e7ee6c03 |
IEDL.DBID | DR2 |
ISSN | 1094-7159 1525-1403 |
IngestDate | Thu Aug 21 14:11:55 EDT 2025 Fri Jul 11 15:07:33 EDT 2025 Fri Jul 25 07:08:44 EDT 2025 Wed Feb 19 02:27:02 EST 2025 Tue Jul 01 03:25:39 EDT 2025 Thu Apr 24 23:12:37 EDT 2025 Wed Aug 20 07:26:45 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | tremor movement disorders Essential tremor peripheral nerve stimulation neurostimulation noninvasive stimulation |
Language | English |
License | Attribution-NonCommercial-NoDerivs https://www.elsevier.com/tdm/userlicense/1.0 http://creativecommons.org/licenses/by-nc-nd/4.0 2019 The Authors. Neuromodulation: Technology at the Neural Interface published by Wiley Periodicals, Inc. on behalf of International Neuromodulation Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4430-682e2da4f2de90aaa6c2c176dea72a6271017c4de49c5a237bb295c31e7ee6c03 |
Notes | Dr. Pahwa has received consulting fees from Abbvie, Abbott, ACADIA, Acorda, Adamas, Cala Health, Cynapsus, Global Kinetics, Ionis, Lundbeck, Neurocrine, Sunovion, Teva Neuroscience, UCB, and US World Meds. He has received research grants from Abbott, AbbVie, Acorda, Adamas, Biogen, BMS, Boston Scientific, Cala Health, Cavion, Cynapsus, Intec, Jazz, Kyowa, Lilly, Parkinson's Foundation, NIH/NINDS, Parkinson Study Group, Pfizer, Roche, Sunovion, and US WorldMeds. Dr. Dhall is an investigator for Cala Health, Inc., and has served as a consultant for Impax, Merz, Teva, and Acadia Pharmaceuticals. Dr. Ostrem received research support from NIH grants R01NS090913, UH3NS100544, DARPA contract W911NF1420043, ad PCORI contract 782.002 as a co‐investigator. Dr. Ostrem also has received research grant support from The National Parkinson Foundation, Michael J. Fox Foundation, Boston Scientific, St Jude Medical, Cala Health, Google, Sangamo, and Biogen. She has been a consultant for Abbvie, Neurocrine, Medtronic, and Adamas Pharmaceutics. She receives programmatic fellowship training support from Medtronic, Abbvie, Boston Scientific, and Allergan. Dr. Lyons has received consulting fees from ACADIA, Parkinson's Foundation, and Sage Therapeutics. She is also President of the International Essential Tremor Foundation. Dr. Ross is employed by Cala Health, Inc. and receives research support at the Mayo Clinic from DARPA contracts N66001‐17‐2‐4010 and N66001‐17‐2‐4018. Dr. Hamner and Ms. Chidester are employed by Cala Health, Inc. Dr. Delp has received research support from NIH grants U54 EB020405, P2C HD065690, R01 GM107340, R01 NS080954, and DARPA contract W911QX12C0018 on which he is the principal investigator. He also has received support from NIH grant R01 EB009351 as a co‐investigator. Dr. Delp is a consultant, scientific advisor, and board member of Cala Health, Inc., Circuit Therapeutics Inc., and Zebra Medical Technologies, Inc. and receives compensation for this service. Drs. Ro, Gwinn, and Luthra have no potential conflict of interest to report. Conflict of Interest ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 Conflict of Interest: Dr. Pahwa has received consulting fees from Abbvie, Abbott, ACADIA, Acorda, Adamas, Cala Health, Cynapsus, Global Kinetics, Ionis, Lundbeck, Neurocrine, Sunovion, Teva Neuroscience, UCB, and US World Meds. He has received research grants from Abbott, AbbVie, Acorda, Adamas, Biogen, BMS, Boston Scientific, Cala Health, Cavion, Cynapsus, Intec, Jazz, Kyowa, Lilly, Parkinson's Foundation, NIH/NINDS, Parkinson Study Group, Pfizer, Roche, Sunovion, and US WorldMeds. Dr. Dhall is an investigator for Cala Health, Inc., and has served as a consultant for Impax, Merz, Teva, and Acadia Pharmaceuticals. Dr. Ostrem received research support from NIH grants R01NS090913, UH3NS100544, DARPA contract W911NF1420043, ad PCORI contract 782.002 as a co‐investigator. Dr. Ostrem also has received research grant support from The National Parkinson Foundation, Michael J. Fox Foundation, Boston Scientific, St Jude Medical, Cala Health, Google, Sangamo, and Biogen. She has been a consultant for Abbvie, Neurocrine, Medtronic, and Adamas Pharmaceutics. She receives programmatic fellowship training support from Medtronic, Abbvie, Boston Scientific, and Allergan. Dr. Lyons has received consulting fees from ACADIA, Parkinson's Foundation, and Sage Therapeutics. She is also President of the International Essential Tremor Foundation. Dr. Ross is employed by Cala Health, Inc. and receives research support at the Mayo Clinic from DARPA contracts N66001‐17‐2‐4010 and N66001‐17‐2‐4018. Dr. Hamner and Ms. Chidester are employed by Cala Health, Inc. Dr. Delp has received research support from NIH grants U54 EB020405, P2C HD065690, R01 GM107340, R01 NS080954, and DARPA contract W911QX12C0018 on which he is the principal investigator. He also has received support from NIH grant R01 EB009351 as a co‐investigator. Dr. Delp is a consultant, scientific advisor, and board member of Cala Health, Inc., Circuit Therapeutics Inc., and Zebra Medical Technologies, Inc. and receives compensation for this service. Drs. Ro, Gwinn, and Luthra have no potential conflict of interest to report. Source(s) of financial support: Supported by Cala Health, Inc. |
ORCID | 0000-0003-3274-6328 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fner.12930 |
PMID | 30701655 |
PQID | 2258716271 |
PQPubID | 1096366 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6766922 proquest_miscellaneous_2179538906 proquest_journals_2258716271 pubmed_primary_30701655 crossref_primary_10_1111_ner_12930 crossref_citationtrail_10_1111_ner_12930 wiley_primary_10_1111_ner_12930_NER12930 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2019 |
PublicationDateYYYYMMDD | 2019-07-01 |
PublicationDate_xml | – month: 07 year: 2019 text: July 2019 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Oxford – name: Hoboken |
PublicationTitle | Neuromodulation (Malden, Mass.) |
PublicationTitleAlternate | Neuromodulation |
PublicationYear | 2019 |
Publisher | Elsevier Limited John Wiley and Sons Inc |
Publisher_xml | – name: Elsevier Limited – name: John Wiley and Sons Inc |
References | 2015; 35 2015; 2 2017; 41 2015; 4 1987; 50 1954; 25 1997; 42 1986; 36 1999; 66 2011; 10 2014; 29 1991; 337 2008; 100 1992; 32 1996; 15 2018; 9 2016; 7 2004; 31 1993; 56 2014; 4 2004; 92 2017; 92 2000; 13 2017; 11 2017; 33 2018; 378 1999; 14 2005; 4 2016; 375 1994; 35 2000; 342 2003; 61 2018; 33 2006; 129 2014; 120 1989; 39 1998; 13 Koller (10.1111/ner.12930_bib14) 1997; 42 Lin (10.1111/ner.12930_bib24) 2018; 33 Zirh (10.1111/ner.12930_bib12) 1999; 66 Riederer (10.1111/ner.12930_bib29) 2015; 4 Elias (10.1111/ner.12930_bib13) 2016; 375 Schuurman (10.1111/ner.12930_bib16) 2000; 342 Hassler (10.1111/ner.12930_bib11) 1954; 25 Cooper (10.1111/ner.12930_bib38) 2000; 13 Koller (10.1111/ner.12930_bib4) 1986; 36 Fenoy (10.1111/ner.12930_bib32) 2014; 120 Putzke (10.1111/ner.12930_bib31) 2004; 31 Elble (10.1111/ner.12930_bib25) 2006; 129 Louis (10.1111/ner.12930_bib1) 1998; 13 Brittain (10.1111/ner.12930_bib9) 2015; 35 Benabid (10.1111/ner.12930_bib15) 1991; 337 Daneault (10.1111/ner.12930_bib35) 2018; 9 Shalaby (10.1111/ner.12930_bib5) 2016; 7 Pathak (10.1111/ner.12930_bib30) 2014; 29 Kestenbaum (10.1111/ner.12930_bib19) 2015; 2 James (10.1111/ner.12930_bib27) 1996; 15 Pozos (10.1111/ner.12930_bib39) 1992; 32 Koller (10.1111/ner.12930_bib17) 1999; 14 Gallego (10.1111/ner.12930_bib23) 2015; 35 Edwards (10.1111/ner.12930_bib18) 2017; 92 Costa (10.1111/ner.12930_bib21) 2008; 100 Deuschl (10.1111/ner.12930_bib26) 2011; 10 Schuhmayer (10.1111/ner.12930_bib34) 2017; 41 Syrkin-Nikolau (10.1111/ner.12930_bib40) 2017; 33 Louis (10.1111/ner.12930_bib2) 2014; 4 Louis (10.1111/ner.12930_bib6) 2005; 4 Hanajima (10.1111/ner.12930_bib20) 2004; 92 Cleeves (10.1111/ner.12930_bib36) 1987; 50 Deuschl (10.1111/ner.12930_bib7) 1998; 13 Britton (10.1111/ner.12930_bib37) 1993; 56 Dideriksen (10.1111/ner.12930_bib22) 2017; 11 Dogu (10.1111/ner.12930_bib3) 2003; 61 Louis (10.1111/ner.12930_bib8) 2016; 375 Koller (10.1111/ner.12930_bib33) 1989; 39 Haubenberger (10.1111/ner.12930_bib10) 2018; 378 Ben-Menachem (10.1111/ner.12930_bib28) 1994; 35 |
References_xml | – volume: 42 start-page: 292 year: 1997 end-page: 299 article-title: High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor publication-title: Ann Neurol – volume: 11 start-page: 178 year: 2017 article-title: Electrical stimulation of afferent pathways for the suppression of pathological tremor publication-title: Front Neurosci – volume: 35 start-page: 8925 year: 2015 end-page: 8937 article-title: The phase difference between neural drives to antagonist muscles in essential tremor is associated with the relative strength of supraspinal and afferent input publication-title: J Neurosci – volume: 100 start-page: 1610 year: 2008 end-page: 1621 article-title: Subcortical interactions between somatosensory stimuli of different modalities and their temporal profile publication-title: J Neurophysiol – volume: 2 start-page: 384 year: 2015 end-page: 387 article-title: Estimating the proportion of essential tremor and Parkinson's disease patients undergoing deep brain stimulation surgery: five‐year data from Columbia University medical center (2009‐2014) publication-title: Mov Disord Clin Pract – volume: 15 start-page: 1421 year: 1996 end-page: 1434 article-title: An index for assessing blindness in a multi‐Centre clinical trial: Disulfiram for alcohol cessation–a VA cooperative study publication-title: Stat Med – volume: 9 start-page: 257 year: 2018 article-title: Could wearable and mobile technology improve the management of essential tremor? publication-title: Front Neurol – volume: 337 start-page: 403 year: 1991 end-page: 406 article-title: Long‐term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus publication-title: Lancet – volume: 120 start-page: 132 year: 2014 end-page: 139 article-title: Risks of common complications in deep brain stimulation surgery: management and avoidance publication-title: J Neurosurg – volume: 41 start-page: 79 year: 2017 end-page: 85 article-title: Task‐dependent variability of essential tremor publication-title: Parkinsonism Relat Disord – volume: 7 start-page: 60 year: 2016 article-title: Public knowledge and attitude toward essential tremor: a questionnaire survey publication-title: Front Neurol – volume: 375 start-page: 730 year: 2016 end-page: 739 article-title: A randomized trial of focused ultrasound thalamotomy for essential tremor publication-title: N Engl J Med – volume: 378 start-page: 1802 year: 2018 end-page: 1810 article-title: Essential Tremor publication-title: N Engl J Med – volume: 33 start-page: 179 year: 2017 end-page: 180 article-title: Coordinated reset vibrotactile stimulation shows prolonged improvement in Parkinson's disease publication-title: Mov Disord – volume: 13 start-page: 276 year: 2000 end-page: 288 article-title: The effect of temperature on hand function in patients with tremor publication-title: J Hand Ther – volume: 4 start-page: 100 year: 2005 end-page: 110 article-title: Essential tremor publication-title: Lancet Neurol – volume: 342 start-page: 461 year: 2000 end-page: 468 article-title: A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor publication-title: N Engl J Med – volume: 92 start-page: 1427 year: 2017 end-page: 1444 article-title: Neurostimulation devices for the treatment of neurologic disorders publication-title: Mayo Clin Proc – volume: 39 start-page: 1587 year: 1989 end-page: 1588 article-title: Acute and chronic effects of propranolol and primidone in essential tremor publication-title: Neurology – volume: 92 start-page: 3171 year: 2004 end-page: 3182 article-title: Very fast oscillations evoked by median nerve stimulation in the human thalamus and subthalamic nucleus publication-title: J Neurophysiol – volume: 31 start-page: 333 year: 2004 end-page: 342 article-title: Thalamic deep brain stimulation for essential tremor: recommendations for long‐term outcome analysis publication-title: Can J Neurol Sci – volume: 56 start-page: 1085 year: 1993 end-page: 1089 article-title: Modulation of postural tremors at the wrist by supramaximal electrical median nerve shocks in essential tremor, Parkinson's disease and normal subjects mimicking tremor publication-title: J Neurol Neurosurg Psychiatry – volume: 129 start-page: 2660 year: 2006 end-page: 2666 article-title: Tremor amplitude is logarithmically related to 4‐ and 5‐point tremor rating scales publication-title: Brain – volume: 375 start-page: 792 year: 2016 end-page: 793 article-title: Treatment of medically refractory essential tremor publication-title: N Engl J Med – volume: 32 start-page: 369 year: 1992 end-page: 372 article-title: Effects of topical anesthesia on essential tremor publication-title: Electromyogr Clin Neurophysiol – volume: 25 start-page: 441 year: 1954 end-page: 447 article-title: Indications and localization of stereotactic brain operations publication-title: Nervenarzt – volume: 66 start-page: 772 year: 1999 end-page: 775 article-title: Stereotactic thalamotomy in the treatment of essential tremor of the upper extremity: reassessment including a blinded measure of outcome publication-title: J Neurol Neurosurg Psychiatry – volume: 4 start-page: 259 year: 2014 article-title: How many people in the USA have essential tremor? Deriving a population estimate based on epidemiological data publication-title: Tremor Other Hyperkinet Mov (N Y) – volume: 13 start-page: 2 year: 1998 end-page: 23 article-title: Consensus statement of the Movement Disorder Society on tremor publication-title: Ad Hoc Scientific Committee Mov Disord – volume: 61 start-page: 1804 year: 2003 end-page: 1806 article-title: Prevalence of essential tremor: door‐to‐door neurologic exams in Mersin Province, Turkey publication-title: Neurology – volume: 35 start-page: 795 year: 2015 end-page: 806 article-title: Distinguishing the central drive to tremor in Parkinson's disease and essential tremor publication-title: J Neurosci – volume: 29 start-page: 838 year: 2014 end-page: 842 article-title: A noninvasive handheld assistive device to accommodate essential tremor: a pilot study publication-title: Mov Disord – volume: 14 start-page: 847 year: 1999 end-page: 850 article-title: Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor publication-title: Mov Disord – volume: 50 start-page: 704 year: 1987 end-page: 708 article-title: Variability in amplitude of untreated essential tremor publication-title: J Neurol Neurosurg Psychiatry – volume: 35 start-page: 616 year: 1994 end-page: 626 article-title: Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First international Vagus nerve stimulation study group publication-title: Epilepsia – volume: 36 start-page: 1001 year: 1986 end-page: 1004 article-title: Disability in essential tremor: effect of treatment publication-title: Neurology – volume: 33 start-page: 1182 year: 2018 end-page: 1183 article-title: Noninvasive neuromodulation in essential tremor demonstrates relief in a sham‐controlled pilot trial publication-title: Mov Disord – volume: 10 start-page: 148 year: 2011 end-page: 161 article-title: Treatment of patients with essential tremor publication-title: Lancet Neurol – volume: 13 start-page: 5 year: 1998 end-page: 10 article-title: How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world publication-title: Mov Disord – volume: 4 start-page: 135 year: 2015 end-page: 147 article-title: Transcutaneous supraorbital nerve stimulation (t‐SNS) with the Cefaly((R)) device for migraine prevention: a review of the available data publication-title: Pain Ther – volume: 9 start-page: 257 year: 2018 ident: 10.1111/ner.12930_bib35 article-title: Could wearable and mobile technology improve the management of essential tremor? publication-title: Front Neurol doi: 10.3389/fneur.2018.00257 – volume: 35 start-page: 616 year: 1994 ident: 10.1111/ner.12930_bib28 article-title: Vagus nerve stimulation for treatment of partial seizures: 1. A controlled study of effect on seizures. First international Vagus nerve stimulation study group publication-title: Epilepsia doi: 10.1111/j.1528-1157.1994.tb02482.x – volume: 10 start-page: 148 year: 2011 ident: 10.1111/ner.12930_bib26 article-title: Treatment of patients with essential tremor publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70322-7 – volume: 4 start-page: 100 year: 2005 ident: 10.1111/ner.12930_bib6 article-title: Essential tremor publication-title: Lancet Neurol doi: 10.1016/S1474-4422(05)00991-9 – volume: 66 start-page: 772 year: 1999 ident: 10.1111/ner.12930_bib12 article-title: Stereotactic thalamotomy in the treatment of essential tremor of the upper extremity: reassessment including a blinded measure of outcome publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.66.6.772 – volume: 342 start-page: 461 year: 2000 ident: 10.1111/ner.12930_bib16 article-title: A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor publication-title: N Engl J Med doi: 10.1056/NEJM200002173420703 – volume: 25 start-page: 441 year: 1954 ident: 10.1111/ner.12930_bib11 article-title: Indications and localization of stereotactic brain operations publication-title: Nervenarzt – volume: 35 start-page: 8925 year: 2015 ident: 10.1111/ner.12930_bib23 article-title: The phase difference between neural drives to antagonist muscles in essential tremor is associated with the relative strength of supraspinal and afferent input publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0106-15.2015 – volume: 33 start-page: 1182 year: 2018 ident: 10.1111/ner.12930_bib24 article-title: Noninvasive neuromodulation in essential tremor demonstrates relief in a sham-controlled pilot trial publication-title: Mov Disord doi: 10.1002/mds.27350 – volume: 11 start-page: 178 year: 2017 ident: 10.1111/ner.12930_bib22 article-title: Electrical stimulation of afferent pathways for the suppression of pathological tremor publication-title: Front Neurosci doi: 10.3389/fnins.2017.00178 – volume: 13 start-page: 2 year: 1998 ident: 10.1111/ner.12930_bib7 article-title: Consensus statement of the Movement Disorder Society on tremor publication-title: Ad Hoc Scientific Committee Mov Disord doi: 10.1002/mds.870131303 – volume: 35 start-page: 795 year: 2015 ident: 10.1111/ner.12930_bib9 article-title: Distinguishing the central drive to tremor in Parkinson’s disease and essential tremor publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3768-14.2015 – volume: 14 start-page: 847 year: 1999 ident: 10.1111/ner.12930_bib17 article-title: Efficacy of unilateral deep brain stimulation of the VIM nucleus of the thalamus for essential head tremor publication-title: Mov Disord doi: 10.1002/1531-8257(199909)14:5<847::AID-MDS1021>3.0.CO;2-G – volume: 100 start-page: 1610 year: 2008 ident: 10.1111/ner.12930_bib21 article-title: Subcortical interactions between somatosensory stimuli of different modalities and their temporal profile publication-title: J Neurophysiol doi: 10.1152/jn.90412.2008 – volume: 42 start-page: 292 year: 1997 ident: 10.1111/ner.12930_bib14 article-title: High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor publication-title: Ann Neurol doi: 10.1002/ana.410420304 – volume: 92 start-page: 1427 year: 2017 ident: 10.1111/ner.12930_bib18 article-title: Neurostimulation devices for the treatment of neurologic disorders publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2017.05.005 – volume: 31 start-page: 333 year: 2004 ident: 10.1111/ner.12930_bib31 article-title: Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysis publication-title: Can J Neurol Sci doi: 10.1017/S0317167100003413 – volume: 50 start-page: 704 year: 1987 ident: 10.1111/ner.12930_bib36 article-title: Variability in amplitude of untreated essential tremor publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.50.6.704 – volume: 56 start-page: 1085 year: 1993 ident: 10.1111/ner.12930_bib37 article-title: Modulation of postural tremors at the wrist by supramaximal electrical median nerve shocks in essential tremor, Parkinson’s disease and normal subjects mimicking tremor publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.56.10.1085 – volume: 29 start-page: 838 year: 2014 ident: 10.1111/ner.12930_bib30 article-title: A noninvasive handheld assistive device to accommodate essential tremor: a pilot study publication-title: Mov Disord doi: 10.1002/mds.25796 – volume: 32 start-page: 369 year: 1992 ident: 10.1111/ner.12930_bib39 article-title: Effects of topical anesthesia on essential tremor publication-title: Electromyogr Clin Neurophysiol – volume: 13 start-page: 5 year: 1998 ident: 10.1111/ner.12930_bib1 article-title: How common is the most common adult movement disorder? Estimates of the prevalence of essential tremor throughout the world publication-title: Mov Disord doi: 10.1002/mds.870130105 – volume: 15 start-page: 1421 year: 1996 ident: 10.1111/ner.12930_bib27 article-title: An index for assessing blindness in a multi-Centre clinical trial: Disulfiram for alcohol cessation–a VA cooperative study publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(19960715)15:13<1421::AID-SIM266>3.0.CO;2-H – volume: 375 start-page: 730 year: 2016 ident: 10.1111/ner.12930_bib13 article-title: A randomized trial of focused ultrasound thalamotomy for essential tremor publication-title: N Engl J Med doi: 10.1056/NEJMoa1600159 – volume: 13 start-page: 276 year: 2000 ident: 10.1111/ner.12930_bib38 article-title: The effect of temperature on hand function in patients with tremor publication-title: J Hand Ther doi: 10.1016/S0894-1130(00)80019-8 – volume: 39 start-page: 1587 year: 1989 ident: 10.1111/ner.12930_bib33 article-title: Acute and chronic effects of propranolol and primidone in essential tremor publication-title: Neurology doi: 10.1212/WNL.39.12.1587 – volume: 61 start-page: 1804 year: 2003 ident: 10.1111/ner.12930_bib3 article-title: Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey publication-title: Neurology doi: 10.1212/01.WNL.0000099075.19951.8C – volume: 378 start-page: 1802 year: 2018 ident: 10.1111/ner.12930_bib10 article-title: Essential Tremor publication-title: N Engl J Med doi: 10.1056/NEJMcp1707928 – volume: 92 start-page: 3171 year: 2004 ident: 10.1111/ner.12930_bib20 article-title: Very fast oscillations evoked by median nerve stimulation in the human thalamus and subthalamic nucleus publication-title: J Neurophysiol doi: 10.1152/jn.00363.2004 – volume: 129 start-page: 2660 year: 2006 ident: 10.1111/ner.12930_bib25 article-title: Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales publication-title: Brain doi: 10.1093/brain/awl190 – volume: 41 start-page: 79 year: 2017 ident: 10.1111/ner.12930_bib34 article-title: Task-dependent variability of essential tremor publication-title: Parkinsonism Relat Disord doi: 10.1016/j.parkreldis.2017.05.018 – volume: 337 start-page: 403 year: 1991 ident: 10.1111/ner.12930_bib15 article-title: Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus publication-title: Lancet doi: 10.1016/0140-6736(91)91175-T – volume: 7 start-page: 60 year: 2016 ident: 10.1111/ner.12930_bib5 article-title: Public knowledge and attitude toward essential tremor: a questionnaire survey publication-title: Front Neurol doi: 10.3389/fneur.2016.00060 – volume: 375 start-page: 792 year: 2016 ident: 10.1111/ner.12930_bib8 article-title: Treatment of medically refractory essential tremor publication-title: N Engl J Med doi: 10.1056/NEJMe1606517 – volume: 4 start-page: 259 year: 2014 ident: 10.1111/ner.12930_bib2 article-title: How many people in the USA have essential tremor? Deriving a population estimate based on epidemiological data publication-title: Tremor Other Hyperkinet Mov (N Y) doi: 10.5334/tohm.198 – volume: 2 start-page: 384 year: 2015 ident: 10.1111/ner.12930_bib19 article-title: Estimating the proportion of essential tremor and Parkinson’s disease patients undergoing deep brain stimulation surgery: five-year data from Columbia University medical center (2009-2014) publication-title: Mov Disord Clin Pract doi: 10.1002/mdc3.12185 – volume: 36 start-page: 1001 year: 1986 ident: 10.1111/ner.12930_bib4 article-title: Disability in essential tremor: effect of treatment publication-title: Neurology doi: 10.1212/WNL.36.7.1001 – volume: 4 start-page: 135 year: 2015 ident: 10.1111/ner.12930_bib29 article-title: Transcutaneous supraorbital nerve stimulation (t-SNS) with the Cefaly((R)) device for migraine prevention: a review of the available data publication-title: Pain Ther doi: 10.1007/s40122-015-0039-5 – volume: 120 start-page: 132 year: 2014 ident: 10.1111/ner.12930_bib32 article-title: Risks of common complications in deep brain stimulation surgery: management and avoidance publication-title: J Neurosurg doi: 10.3171/2013.10.JNS131225 – volume: 33 start-page: 179 year: 2017 ident: 10.1111/ner.12930_bib40 article-title: Coordinated reset vibrotactile stimulation shows prolonged improvement in Parkinson’s disease publication-title: Mov Disord doi: 10.1002/mds.27223 |
SSID | ssj0017927 |
Score | 2.4146106 |
Snippet | Objective
To evaluate the safety and effectiveness of a wrist‐worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single... To evaluate the safety and effectiveness of a wrist-worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single in-office... ObjectiveTo evaluate the safety and effectiveness of a wrist‐worn peripheral nerve stimulation device in patients with essential tremor (ET) in a single... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 537 |
SubjectTerms | Activities of daily living Activities of Daily Living - psychology Aged Aged, 80 and over Clinical Trials Essential tremor Essential Tremor - diagnosis Essential Tremor - physiopathology Essential Tremor - therapy Female Hand Humans Male Middle Aged movement disorders neurostimulation noninvasive stimulation Patients PERIPHERAL NERVE STIMULATION Peripheral nerves Peripheral Nerves - physiology Transcutaneous Electric Nerve Stimulation - instrumentation Transcutaneous Electric Nerve Stimulation - methods Tremor Wrist Wrist - innervation Wrist - physiology |
Title | An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fner.12930 https://www.ncbi.nlm.nih.gov/pubmed/30701655 https://www.proquest.com/docview/2258716271 https://www.proquest.com/docview/2179538906 https://pubmed.ncbi.nlm.nih.gov/PMC6766922 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxsxEBZpTr30lT6cpEEtpfSyxqvVSll6MsEhFGqC60AOhUUrzVITWw72upD8-s5oH8RNAqU3gUasVprRzEifPjH2yaSAE1vGkbDCROQxoqyUxxEIiJWSBUbBtN_xfazOLuS3y_Ryh31t78LU_BDdhhtZRlivycBNsb5j5B5WfXJWlK8TVosCoklHHYV6Fp5rjTF9iTT67IZViFA8XcttX3QvwLyPk7wbvwYHdPqc_Wy7XuNOrvqbqujb279YHf_z316wZ01gyoe1Jr1kO-Bfsb2hx6R8ccM_8wAVDXvwe8wNPR_aTQV8YrxbLma34PhJDXqfY3FKWs2XJR_TZu9vQxB5fo66HjgM5nxMMEv-o5otmsfD-Mzz0ZruQVHD6Yrgv6_ZxeloenIWNc81RFbKBJPQYwHCGVkKB9nAGKOssLFWDowWRglN1m-lA5nZ1IhEF4XIUpvEoAGUHSRv2K5fenjHuDZWg3PGlI6OrGMTO4ni1tC5JyRpj31pJy63DZc5Pakxz9ucBkcwDyPYYx870euawOMhocN29vPGhtc5rnSUTWK_e-xDV43WR0cqxsNygzKoZ-gysoHqsbe1snRfodU0Vil2Vm-pUSdAzN7bNX72KzB8K61UJgT-ZtCSxzuej0eTUNj_d9ED9hSjvqzGHB-y3Wq1gfcYWVXFEXsi5PlRMKQ_f-IiVA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBelfdhe9tV9pOs2bYyxF4dYtqUa9hJKSra1ZmQp9GUYWTqzsEQpqVNo__reyR806wZjbwafsSzd6T708-8Ye68TwIUtw0AYoQPyGEFaxgcBCAiljAuMgqnecZLJ8Wn85Sw522Kf2n9han6IruBGluH3azJwKkjfsnIHqz55K0zYd6ijt0-oJh15FGqab9gaYgITKPTaDa8Q4Xi6Rze90Z0Q8y5S8nYE613Q0UP2ox18jTz51V9XRd9c_8br-L9f94g9aGJTPqyV6THbAveE7Q4d5uWLK_6Be7SoL8PvMjt0fGjWFfCJdna5mF2D5Yc17n2Ol1NSbL4seUb13ktNKHn-DdXd0xjMeUZIS_69mi2a_mF85vjogn6FogenK0IAP2WnR6Pp4ThoOjYEJo4jzEMPBAir41JYSAdaa2mECZW0oJXQUijaAExsIU5NokWkikKkiYlCUADSDKJnbNstHbxgXGmjwFqtS0un1qEObYziRtPRJ0RJj31sVy43DZ05ddWY521agzOY-xnssXed6HnN4fEnof12-fPGjC9y3OwoocRx99jb7jYaIJ2qaAfLNcqgoqHXSAeyx57X2tK9hTbUUCY4WLWhR50AkXtv3nGzn57kWyopUyHwM72a_H3geTaa-Iu9fxd9w-6NpyfH-fHn7OtLdh-DwLSGIO-z7Wq1hlcYaFXFa29PN6XNJZg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBalg7GX3bpL2m7Txhh7cYhlW4rZU2gTupspWQp9GBhZOmZhiVJSZ7D--p0jX2jWDcbeDD7GsvQdnXOkz58Ye60TwIEtw0AYoQOKGEFaxsMABIRSxgVmwbTe8TmTJ2fxh_PkfIe9a_-FqfUhugU38gw_X5ODX9jympM7WPcpWGG9fiuWgyFB-njaaUch0Px5rSHWL4HCoN3IChGNp3t0OxjdyDBvEiWvJ7A-Ak3usa9t22viyff-pir65uo3Wcf__Lj77G6TmfJRDaUHbAfcQ7Y3cliVL3_yN9xzRf0i_B6zI8dHZlMBn2pnV8v5FVh-VLPeF3g5I1jzVckzWu39oYkjz08R7F7EYMEz4lnyL9V82ZwexueOjy_pRyh6cLYm_u8jdjYZz45Ogua8hsDEcYRV6FCAsDouhYV0oLWWRphQSQtaCS2FIvc3sYU4NYkWkSoKkSYmCkEBSDOIHrNdt3LwlHGljQJrtS4t7VmHOrQxmhtNG58QJT32th243DRi5nSmxiJvixrswdz3YI-96kwvagWPPxkdtqOfN058meNUR-UktrvHXna30f1oT0U7WG3QBnGGMSMdyB57UoOlewtNp6FMsLFqC0adAUl7b99x829e4lsqKVMh8DM9Sv7e8DwbT_3F_r-bvmC3T48n-af32ccDdgczwLTmHx-y3Wq9gWeYZVXFc-9NvwBC8iRQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+Acute+Randomized+Controlled+Trial+of+Noninvasive+Peripheral+Nerve+Stimulation+in+Essential+Tremor&rft.jtitle=Neuromodulation+%28Malden%2C+Mass.%29&rft.au=Pahwa%2C+Rajesh&rft.au=Dhall%2C+Rohit&rft.au=Ostrem%2C+Jill&rft.au=Gwinn%2C+Ryder&rft.date=2019-07-01&rft.eissn=1525-1403&rft.volume=22&rft.issue=5&rft.spage=537&rft_id=info:doi/10.1111%2Fner.12930&rft_id=info%3Apmid%2F30701655&rft.externalDocID=30701655 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1094-7159&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1094-7159&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1094-7159&client=summon |